Erratum To: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results From an Open-Label, 48-Week Extension Study

Clinical Drug Investigation - United Kingdom
doi 10.1007/s40261-013-0133-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Efficacy, Safety and Tolerability of Escitalopram in Doses Up to 50 Mg in Major Depressive Disorder (MDD): An Open-Label, Pilot Study

BMC Psychiatry
PsychiatryMental Health
2011English

Efficacy and Tolerability of Escitalopram in Treatment of Major Depressive Disorder With Anxiety Symptoms: A 24-Week, Open-Label, Prospective Study in Chinese Population

Neuropsychiatric Disease and Treatment
2017English

Aripiprazole in Children and Adolescents With Tourette's Disorder: An Open-Label Safety and Tolerability Study

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2009English

Safety, Tolerability, and Efficacy of Vortioxetine (Lu AA21004) in Major Depressive Disorder

International Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2014English

Safety and Tolerability of Desvenlafaxine in Children and Adolescents With Major Depressive Disorder

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2014English

Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2015English

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

Journal of Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Symtomatic Factors in Patients With Major Depressive Disorder (MDD): Results From an Observational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy